首页 | 本学科首页   官方微博 | 高级检索  
     

分化型甲状腺癌131I治疗的现状
引用本文:张洁,石洪成. 分化型甲状腺癌131I治疗的现状[J]. 国际放射医学核医学杂志, 2009, 33(3): 163-167. DOI: 10.3760/cma.j.issn.1673-4114.2009.03.009
作者姓名:张洁  石洪成
作者单位:复旦大学附属中山医院核医学科,上海,200032;复旦大学附属中山医院核医学科,上海,200032
摘    要:分化型甲状腺癌的系统治疗包括手术切除、131I治疗、促甲状腺激素(TSH)抑制治疗。131I治疗的有效性得到普遍认可,但在治疗过程中还有很多问题存有争议。

关 键 词:甲状腺肿瘤  碘放射性同位素  近距离放射疗法
收稿时间:2009-02-17

The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma
ZHANG Jie,SHI Hong-cheng. The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2009, 33(3): 163-167. DOI: 10.3760/cma.j.issn.1673-4114.2009.03.009
Authors:ZHANG Jie  SHI Hong-cheng
Affiliation:Department of Nuclear Medicine, Zhongshan Hospital, Shanghai Fudan University, Shanghai 200032, China
Abstract:The systemic treatment of differentiated thyroid carcinoma include thyroidectomy, radioactive iodine and thyroxine suppression of thyroid-stimulating hormone. The effectivity of the iodine-131 therepy were well accepted, but still some of issues were still debatable.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《国际放射医学核医学杂志》浏览原始摘要信息
点击此处可从《国际放射医学核医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号